pharmaceutical marketing strategy

By Casey Ferrell, Senior Research Analyst Our recent survey of pharma companies revealed that 58 percent have dedicated digital marketing groups. I think it’s safe to assume at this point that the digital revolution is real and is only going to continue...

By Jeremy Spivey, Senior Research Analyst Advertising Age reports that Purdue Pharma is planning a major DTC ad campaign for its new product, Intermezzo. Although Intermezzo is based on the same active ingredient molecule as Ambien, a sublingual administration...

By Michelle Vitko, Senior Research Analyst In an earlier blog post, I discussed the cost of patient non-adherence -- poorer health outcomes for patients and billions of dollars in lost product revenue. Low adherence rates have been a problem for a...

By Michelle Vitko, Research Analyst Drug companies are increasingly building centralized Patient Adherence teams, as revealed in our latest study on patient adherence. This is a recent development, with most companies reaching the decision to create...

By Shaylyn Pike,Senior Research Analyst Once upon a time, a brand team's quest ended at marketing approval; revenues would take care of themselves. Fast forward 20 years, and the industry faces a much more challenging road to brand success. Receiving...

By Casey Ferrell,Research Analyst Joining the ever-growing list of organizations, associations and trade groups to weigh in on social media, the American Medical Association this week adopted a non-binding policy suggesting how physicians should go about...

By Michelle Vitko,Research Analyst The Research team is right in the middle of our new study of patient adherence and compliance, and we've now interviewed executives from a variety of companies in the life sciences industry about their patient adherence...

By Casey Ferrell,Research Analyst Well, we’re two thirds of the way through the 2012 ePharma Summit. Day One was a full day of symposia, while Day Two was a mishmash of sessions, keynotes, thought leader panels, futurists, multichannel tracks, examples...

By Casey Ferrell,Research Analyst The ePharma Summit 2012 kicked off with a full day of symposia on three tracks. I attended the Medical, Legal and Regulatory Policy Summit, and as I write this, my head is swimming with interesting facts, perspectives...

By Jeremy Spivey,Senior Research Analyst After years of nurturing its global blockbuster and trying to prepare for patent expiration, Pfizer's Lipitor is finally open to direct generic competition in the United States. Ranbaxy, which has 180 days of...